Skip to main content

EDITORIAL article

Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1459741
This article is part of the Research Topic The Culprit Behind Some Diseases: Overexpression/hyperactivity of G6PD View all 5 articles

Editorial: The Culprit Behind Some Diseases: Overexpression/Hyperactivity of G6PD

Provisionally accepted
Muhammet Karaman Muhammet Karaman 1*Nuray Ulusu Nuray Ulusu 2
  • 1 Kilis 7 Aralık University, Kilis, Türkiye
  • 2 Koç University, Istanbul, Istanbul, Türkiye

The final, formatted version of the article will be published soon.

    Keywords: Glucose 6 phosphate dehydrogenase, Oxitative stress, NADPH, Overexpression of G6PD, alzhaimer disease, Cancer, metabolic disease

    Received: 04 Jul 2024; Accepted: 12 Jul 2024.

    Copyright: © 2024 Karaman and Ulusu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Muhammet Karaman, Kilis 7 Aralık University, Kilis, Türkiye

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.